Neonatal STZ model of type II diabetes mellitus in the Fischer 344 rat: Characteristics and assessment of the status of the hepatic adrenergic receptors

International Journal of Biochemistry and Cell Biology

Volumn 32, Issue 8, 2000, Pages 905-919

  Hemmings, Susan J ^a   Spafford, David ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Glucocounterregulation; Hepatic adrenergic receptors; Neonatal rat; Streptozotocin

Indexed keywords

ADRENERGIC RECEPTOR; CALCIUM CHANNEL; CATECHOLAMINE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DIABETES MELLITUS; DISEASE MODEL; GLUCAGON BLOOD LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; LIVER CELL MEMBRANE; NONHUMAN; RAT; SEX DIFFERENCE;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANIMALS, NEWBORN; BLOOD GLUCOSE; BODY WEIGHT; CALCIUM; CELL MEMBRANE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIETARY FATS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HORMONES; INSULIN; LIVER; MALE; RATS; RATS, INBRED F344; RECEPTORS, ADRENERGIC; SEX CHARACTERISTICS; STREPTOZOCIN; TIME FACTORS;

EID: 0034254974     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(00)00019-4     Document Type: Article

References (54)

1. De Fronzo R.A., Bonadonna R.C., Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care. 15:1992;318-368.
2. Jarvinen Y. Pathogeneis of non-insulin-dependent diabetes mellitus. Lancet. 343:1994;91-95.
3. Turner R.C., Hattersley A.T., Shaw J.T.E., Levy J.C. Type II diabetes: clinical aspects of molecular biological studies. Diabetes. 44:1995;1-10.
4. Coleman D.L. Diabetes-obesity syndromes in mice. Diabetes. 31:(Suppl 1):1982;1-6.
5. Sulakhe S.J. Hepatic adrenergic receptors in the genetically diabetic C57BL/KsJ (db/db) mouse. Int. J. Biochem. 19:1987;118-1186.
6. 1 and β adrenergic receptors in various animal species. Molec. Cell Biochem. 83:1988;81-88.
7. Lefkowitz R.J., Cotecchia S., Kjelsberg M.A., Pitcher J., Koch W.J., Inglese J., Caron M.G. Adrenergic receptors: recent insights into their mechanism of activation and desensitization. Adv. Second Mess. Phosphoprotein Res. 28:1993;1-9.
8. Portha B., Levacher C., Picon L., Rosselin G. Diabetogenic effect of streptozotocin in the rat during the perinatal period. Diabetes. 23:1974;889-895.
9. Movassat J., Saulnier C., Portha B. Insulin administration enhances growth of the β-cell mass in STZ-treated newborn rats. Diabetes. 46:1997;1445-1452.
10. Weir G.C., Clore E.T., Zmachinski C.J., Bonner-Weir S. Islet secretion in a new experimental model for non-insulin-dependent diabetes. Diabetes. 30:1981;590-595.
11. Bonner-Weir S. Regulation of pancreatic β-cell mass in vivo. Recent Progress in Hormone Res. 49:1994;91-104.
12. Iwase M., Kikuchi M., Nunoi K., Wakisaka M., Maki Y., Sadoshima S., Fujishima M. A new model of type 2 (non-insulin-dependent) diabetes in spontaneously hypertensive rats: diabetes induced by neonatal streptozotocin treatment. Diabetologia. 29:1986;808-811.
13. Grill V., Westberg M., Östenson C.-G. β-cell insensitivity in a rat model of non-insulin-dependent diabetes. Evidence for a rapidly reversible effect of previous hyperglycemia. J. Clin. Invest. 80:1987;664-669.
14. Welsh N., Hellerström C. In vitro restoration of insulin production in islets from adult rats treated neonatally with streptozotocin. Endocrinology. 126:1990;1842-1848.
15. Sulakhe S.J. The activity of γ-glutamyltranspeptidase in regenerating rat liver. FEBS Lett. 204:1986;302-306.
16. Sulakhe S.J., Lautt W.W. Characterization of γ-glutamyltranspeptidase in normal, premalignant and malignant rat liver. Int. J. Biochem. 19:1987;23-32.
17. Raabo E., Terkildsen T.C. On the enzymatic determination of blood glucose. Scand. J. Clin. Invest. 12:1960;402.
18. Williamson D.H., Mellanby J., Krebs H.A. Enzymatic determination of D(-) β-hydroxybutyric acid and acetoacetic acid in blood. Biochem. J. 82:1962;90.
19. Sulakhe-Hemmings S.J., Pulga V.B., Trans S. An extended developmental study of γ-glutamyltranspeptidase in rat liver plasma membranes. Molec. Cell Biochem. 115:1992;71-77.
20. Reitman S., Frankel S. A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. Am. J. Clin. Pathol. 28:1957;53-65.
21. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurements with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
22. Michell R.H., Hawthorne J.N. The site of diphosphoinositide synthesis in rat liver. Biochem. Biophys. Res. Commun. 21:1965;333-338.
23. 2- and β-adrenergic receptors in rat liver plasma membranes. Gen. Pharmacol. 19:1988;489-494.
24. Hemmings S.J., Storey K.B. Alterations in hepatic adrenergic receptor status in Rana sylvatica in response to freezing and thawing: implications to the freeze-induced glycemic response. Can. J. Physiol. Pharmacol. 72:1994;1552-1560.
25. Sulakhe S.J., Pulga V.B., Tran S.T. Calcium transport activities of plasma membranes isolated from the livers of various animal species. Comp. Biochem. Physiol. 96A:1990;465-468.
26. Sulakhe S.J., Tran S.T., Pulga V.B. Modulation of γ-glutamyltranspeptidase activity in rat liver plasma membranes by thyroid hormone. Int. J. Biochem. 22:1990;997-1004.
27. Schnedl W.J., Ferber S., Johnson J.H., Newgard C.B. STZ transport and cytotoxicity: specific enhancement in glut2-expressing cells. Diabetes. 43:1994;1326-1333.
28. Trent D.F., Fletcher D.J., May J.M., Bonner-Weir S., Weir G.C. Abnormal islet and adipocyte function in young β-cell deficient rats with near-normoglycemia. Diabetes. 33:1984;170-175.
29. Storlien L.H., Oakes N.D., Pan D.A., Kusunoki M., Jenkins A.B. Syndromes of insulin resistance in the rat: inducement by diet and amelioration with Benfluorer. Diabetes. 42:1993;457-462.
30. Oakes N.D., Cooney G.J., Camilleri S., Chisholm D.J., Kraegen E.W. Mechanism of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes. 46:1997;1768-1774.
31. Man Z.-W., Noma Y., Toide K., Sato T., Asahi Y., Hirashima T., Mori S., Kawano K., Mizuno A., Sano T., Shima K. Impaired β-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM. Diabetes. 46:1997;1718-1724.
32. Blake H.H., Henning S.J. Effect of propylthiouracil dose on serum thyroxine, growth and weaning in young rats. Am. J. Physiol. 248:1985;R524-R530.
33. DiMarco P.N., Chasalberti A.V., Martin C.E., Oliver I.T. Perinatal changes in liver corticosterone, serum insulin and plasma glucagon and corticosterone in the rat. Int. J. Biochem. 87:1978;243-247.
34. McEnvoy R.C., Madson K.L. Pancreatic insulin-, glucagon- and somatostatin-positive cell populations during the perinatal development of the rat. Biol. Neonate. 38:1980;248-259.
35. D'Agostino J., Henning S.J. Role of thyroxine in coordinate expression of corticosterone and CBG in postnatal development. Am. J. Physiol. 242:1982;E33-E39.
36. Suzuki Y., Kita K., Uchigata Y., Takata I., Sato T. Maturation of renal and hepatic monodeiodination of thyroxine to triiodothyronine and post-natal changes of serum thyroid hormones in young rats. Acta Endocrinol. 99:1982;540-545.
37. Peterson O.H., Peterson C.C.H., Kasai H. Calcium and hormone action. Annu. Rev. Physiol. 56:1994;297-319.
38. Bonner-Weir S., Trent D.F., Honey R.N., Weir G.C. Responses of neonatal rat islets to streptozotocin. Limited β-cell regeneration and hyperglycemia. Diabetes. 30:1981;64-69.
39. Tsuji K., Taminato T., Usami M., Ishida H., Kitano N., Fukumoto H., Koh G., Kurose T., Yamada Y., Yano J., Seino Y., Imura H. Characteristic features of insulin secretion in the streptozotocin-induced NIDDM rat model. Metabolism. 37:1988;1040-1044.
40. Leahy J.L., Bonner-Weir S., Weir G.C. β-cell dysfunction induced by chronic hyperglycemia. Diabetes Care. 15:1992;442-455.
41. Malaisse W.J., Giroix M.-H., Dähner D., Marynissen G., Sener A., Portha B. Neonatal streptozotocin injection: a model of glucotoxicity? Metabolism. 40:1991;1101-1105.
42. Robertson R.P., Olson L.K., Zhang H.-J. Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene. Diabetes. 43:1994;1085-1089.
43. Tuch B.E., Grigoriou S., Turtle J.R. Effect of normoglycemia on the functional maturation of the human beta cell. Pancreas. 4:1989;587-593.
44. Tuch B.E., Turtle J.R., Simconovic C.J. Streptozotocin is not toxic to the human fetal β-cell. Diabetologia. 32:1989;678-684.
45. Scheer D.G., Cahnmann H.J., Nikodem V.M. Molecular size of the nuclear thyroid hormone receptor. Biochim. Biophys. Acta. 930:1987;101-106.
46. 1-adrenergic receptor in rat liver is thyroid hormone dependent. Endocrinology. 113:1983;672-676.
47. Arias I.M., Boyer J.L., Faisto N., Jakoby W.R., Schachter D., Shafritz D.A., Exton J.H. Role of inositol triphosphate and diacyl glycerol in the regulation of liver function. The Liver: Biology and Pathobiology. 3rd ed. 1994;933-942 Raven Press, New York.
48. Asplin C.M., Raghu P.K., Koerker D.J., Palmer J.P. Glucose counterregulation during recovery from neuroglucopenia: which mechanism is important? Metabolism. 34:1985;L15-L18.
49. Lecavalier L., Bolli G., Cryer P., Gerig J. Contributions of gluconeogenesis and glycogenolysis during glucose counterregulation in normal humans. Am. J. Physiol. 256:1989;E844-E851.
50. Baker D., Evans M., Cryer P., Sherwin R. Hypoglycemia and glucose sensing. Diabetologia. 40:1997;B83-B88.
51. Lautt W.W. Hepatic nerves: a review of their functions and effects. Can. J. Physiol. Pharmacol. 58:1980;105-123.
52. Lautt W.W. Afferent and efferent neural roles in liver function. Prog. Neurobiol. 21:1983;323-348.
53. Bolli G.B., Tsalikian E., Haymond M.W., Cryer P.E., Gerich J.E. Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. J. Clin. Invest. 73:1984;1532-1541.
54. Olefsky J.M., Sherwin R.S. Diabetes mellitus: management and complications. 1985;Churchill Livingstone, New York.